gusperimus has been researched along with everolimus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diaz-Romero, J; Vogt, G; Weckbecker, G | 1 |
| Gfeller, P; Katopodis, A; Metzler, B; Wieczorek, G | 1 |
2 other study(ies) available for gusperimus and everolimus
| Article | Year |
|---|---|
Coexpression of CD4 and CD8alpha on rat T-cells in whole blood: a sensitive marker for monitoring T-cell immunosuppressive drugs.
Topics: Animals; Biomarkers; CD4 Antigens; CD4-Positive T-Lymphocytes; CD8 Antigens; Concanavalin A; Cyclosporine; Everolimus; Fingolimod Hydrochloride; Flow Cytometry; Guanidines; Immunosuppressive Agents; Mitogens; Propylene Glycols; Rats; Rats, Inbred Lew; Sirolimus; Sphingosine; Tacrolimus | 2001 |
Differential promotion of hematopoietic chimerism and inhibition of alloreactive T cell proliferation by combinations of anti-CD40Ligand, anti-LFA-1, everolimus, and deoxyspergualin.
Topics: Animals; Antibodies, Monoclonal; CD40 Ligand; Cell Proliferation; Chimerism; Everolimus; Graft Rejection; Guanidines; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Immunosuppressive Agents; Lymphocyte Depletion; Lymphocyte Function-Associated Antigen-1; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Sirolimus; Skin Transplantation; T-Lymphocytes | 2008 |